Interim trial data shows low effectiveness for CureVac shot
German vaccine maker CureVac says interim data from late-stage testing of its coronavirus shot show a comparatively low...
German vaccine maker CureVac says interim data from late-stage testing of its coronavirus shot show a comparatively low...
The U.K. government announced Friday that it plans to work with a German biopharmaceutical company to develop vaccines t...
U.K.-based drugmaker GlaxoSmithKline and Germany’s CureVac say they plan to collaborate to develop new vaccines that can...